BackCeryvyn Therapeutics Limited Overview

Ceryvyn Therapeutics Limited Goodwill

Ceryvyn Therapeutics Limited's goodwill is $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Ceryvyn Therapeutics Limited Goodwill History

Loading

Ceryvyn Therapeutics Limited vs. peers: Goodwill Comparison

Loading

Ceryvyn Therapeutics Limited Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ceryvyn Therapeutics Limited (CKDXF) FAQ

Ceryvyn Therapeutics Limited (CKDXF) currently reports a goodwill of $0 as of December 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Ceryvyn Therapeutics Limited's goodwill history and peer comparisons.

Ceryvyn Therapeutics Limited's goodwill changed from $0 to $0 (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ceryvyn Therapeutics Limited reported $0 in goodwill as of December 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ceryvyn Therapeutics Limited, and consider following CKDXF for alerts when major investors trade the stock.

Ceryvyn Therapeutics Limited is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CKDXF with unrelated industries.